Live from the NIH registry
Studies recruiting near Round Lake Beach right now
Top 25 of 476 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10041, Island Lake, IL — Island Lake, Illinois (9.1 mi)
· Sponsor: Colorado Prevention Center
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Orchard Healthcare Research Inc. — Skokie, Illinois (29.8 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope® Cancer Center Chicago — Zion, Illinois (13.5 mi)
· Sponsor: Hoffmann-La Roche
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Advocate Medical Group-Park Ridge, Luther Lane-Oncology — Park Ridge, Illinois (28.2 mi)
· Sponsor: Pfizer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Niles, Illinois (28.7 mi)
· Sponsor: Daiichi Sankyo
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Clinical Investigation Specialists, Inc — Gurnee, Illinois (9.2 mi)
· Sponsor: Ardelyx
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: Immuneering Corporation
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Advocate Children's Hospital-Park Ridge — Park Ridge, Illinois (28.2 mi)
· Sponsor: Children's Oncology Group
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Solid Tumours
Phase 2
Interventional 588 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: Boehringer Ingelheim
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Generalized Myasthenia Gravis, gMG
Phase 4
Interventional 75 participants sought
Research Site — Schaumburg, Illinois (23.9 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Endevour Health — Skokie, Illinois (29.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi)
· Sponsor: NRG Oncology
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: Janssen Research & Development, LLC
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: Eastern Cooperative Oncology Group
Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos
Complex Aneuploidy, Chaotic Aneuploidy
N/A
Observational 280 participants sought
Fertility Center of Illinois — Highland Park, Illinois (19.8 mi)
· Sponsor: Shady Grove Fertility Reproductive Science Center
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Midwestern Regional Medical Center — Zion, Illinois (13.5 mi)
· Sponsor: NRG Oncology
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Edward H. Kaplan MD & Associates - Hematology/Oncology of the North Shore — Skokie, Illinois (29.8 mi)
· Sponsor: Gilead Sciences
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Ascension All Saints Hospital-Spring Street-Racine — Racine, Wisconsin (28.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Glenview, IL Investigative Site 10021 — Glenview, Illinois (26.1 mi)
· Sponsor: Colorado Prevention Center
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (25.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: NRG Oncology
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital — Lake Forest, Illinois (14.8 mi)
· Sponsor: Endeavor Health
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,800 participants sought
Clinical Investigation Specialists, Inc. — Kenosha, Wisconsin (19.4 mi)
· Sponsor: TriGemX Bio, Inc.